The Need for Patient Education and Collaborative Treatment

Hello Gout Education,

The Gout Education Society is committed to raising awareness of gout—the most common form of inflammatory arthritis. The Society arms healthcare professionals, like you, with resources to share with patients and staff—and provides you with access to the most up-to-date research and information about gout and treatment options through GoutEducation.org.

This month, the Society is focused on raising awareness of the need for medical professionals to educate patients on the disease, while also acknowledging the importance of collaborative approach when it comes to diagnosis, treatment and management of gout. Gout can require a variety of professionals, not only to manage the effects of gout, but also other health conditions.

Patients often face inadequate care and it's the role of medical professionals to help address this concern. One of the most common causes of inadequate care? Low awareness of the disease from patients.

The most common inadequacies around awareness of the disease include: risk factors, commonly seen comorbid conditions, and treatment options. Providing patients with educational resources is a key tactic to improve awareness of these topics surrounding gout.

However, it's imperative that each medical professional across the patient's care team relay consistent information about the disease. Depending on the level of care needed—whether it be a rheumatologist, nephrologist, podiatrist or others—patients can face conflicting information on the disease. A key takeaway for medical professionals is to work together to develop a management plan.

Want to learn more about the Society's methodology for diagnosing and treating gout and better understand how to work collaboratively? Download the updated medical professional guide or order a print copy today.

To order other educational materials, visit the Contact Us page on the Society's website.

Have any questions or need resources? Email us: [email protected].

New Blog: Demystifying Gout: Not Just About Foods

By: Gary Ho, Gout Support Group of America

Recently, Gary Ho, who has been managed his gout for more than 20 years, wrote a blog post on myths surrounding the disease and tips for those suffering.

Read more about his approach in our latest blog post.

Co-founder of the Gout Support Group of America, Gary spent more than 15 years dealing with the disease before taking charge of the disease. Founded in 2015, the Gout Support Group of America seeks to help those looking to manage the disease find helpful information and provide a platform to interact with the community.

Help Patients Find Gout Treatment Faster!

Are you a part of our Gout Specialists Network (GSN)?

Joining is easy:

1. To sign up, visit GoutSpecialistsNetwork.org.
2. After you register free of charge, update your profile page with information about yourself and your practice.
3. Enjoy ongoing access to the latest gout information, research and continuing education.

As a member, you can choose to make your practice and professional information available to patients through a medical professional locator—helping those with gout find qualified medical professionals in their area.

Clinical Trial Seeks People with Hyperuricemia

Tigulixostat, a xanthine oxidase inhibitor, will be studied in a clinical trial. LG Chem is looking for participants from several different regions.

The Phase 3 clinical trial intends to test the drug’s effectiveness for twelve months in people with hyperuricemia versus those who are given a placebo.

Find out who is eligible and how patients can sign up on clinicaltrials.gov

Clinical Trial Seeks People with an Acute Gout Attack

Olatec Therapeutics is seeking participants for its Phase 2/3 clinical trial in patients with an acute gout flare. The objective of the clinical trial is to test an oral anti-inflammatory, called dapansutrile, which is an investigational drug not yet approved by FDA. The trial will assess the effectiveness of dapansutrile in treating inflammatory pain over 8 days in people with gout who are experiencing an acute gout attack versus those who are given a placebo. Rescue treatment is offered if pain remains intolerable while on study. 

The trial is seeking participants located throughout the USA and in Europe. 

To find out who is eligible and how patients can sign up please visit clinicaltrials.gov and/or contact [email protected] 

Clinical Trial Seeks People Around Houston

Advanced Rheumatology of Houston is seeking participants with diagnosed gout for research on treatment options for the disease. Participants must be willing to commit time for study visits at the practice's clinic in The Woodlands, Texas.

To find out who is eligible and how patients can sign up please contact Advanced Rheumatology of Houston at (936) 681 4882

Stay up to date on the most recent gout news